Concise review: Bone marrow mononuclear cells for the treatment of ischemic syndromes: Medicinal product or cell transplantation?

Stem Cells Translational Medicine

Volumn 1, Issue 5, 2012, Pages 403-408

  Cuende, Natividad ^a   Rico, Laura ^a   Herrera, Concha ^b  

^a Servicio Andaluz de Salud   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Adult stem cells; Advanced therapy medicinal product; Bone marrow transplant; Clinical trials; Stem cell transplantation; Tissue specific stem cells

Indexed keywords

CD133 ANTIGEN; CYTOKINE;

BIOLOGICAL TRAIT; BONE MARROW; BONE MARROW MONONUCLEAR CELL; BONE MARROW TRANSPLANTATION; CELL PROTECTION; CELLULAR SECRETION; HUMAN; ISCHEMIA; KNOWLEDGE; LEGAL ASPECT; MICROCHIMERISM; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REGENERATIVE ABILITY; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE INJURY; ADULT; ANIMAL; BONE MARROW CELL; CELL TRANSPLANTATION; CYTOLOGY;

ADULT; ANIMALS; BONE MARROW CELLS; CELL TRANSPLANTATION; HUMANS; ISCHEMIA;

EID: 84864867010     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2011-0064     Document Type: Review

References (48)

1. Thomas ED, Lochte HL, Jr., Lu WC et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957;257:491-496.
2. Martin-Rendon E, Brunskill S, Dorée C et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2008: CD006536.
3. Suárez de Lezo J, Herrera C, Pan M et al. Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. Rev Esp Cardiol 2007;60:357-365.
4. Schächinger V, Erbs S, Elsässer A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
5. Williams AR, Trachtenberg B, Velazquez DL et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circ Res 2011;108:792-796.
6. Adler DS, Lazarus H, Nair R et al. Safety and efficacy of bone marrow-derived autologous CD133 stem cell therapy. Front Biosci (Elite Ed) 2011;3:506-514.
7. Walter DH, Krankenberg H, Balzer JO et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: A randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 2011;4:26-37.
8. Idei N, Soga J, Hata T et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: A comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv 2011;4:15-25.
9. Scientific recommendation on classification of advanced therapy medicinal products. EMA/920913/2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/11/WC500118208.pdf. Accessed December 10, 2011.
10. Scientific recommendation on classification of advanced therapy medicinal products. EMA/921674/2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/11/WC500118207.pdf. Accessed December 10, 2011.
11. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367.
12. Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402.
13. Challen G, Little M. A side order of stem cells: The SP phenotype. STEM CELLS 2006;24:3-12.
14. Salem HK, Thiemermann C. Mesenchymal stromal cells: Current understanding and clinical status. STEM CELLS 2010;28:585-596.
15. Kucia MJ, Wysoczynski M, Wu W et al. Evidence that very small embryonic-like stem cells are mobilized into peripheral blood. STEM CELLS 2008;26:2083-2092.
16. Ji KH, Xiong J, Hu KM et al. Simultaneous expression of Oct4 and genes of three germ layers in single cell-derived multipotent adult progenitor cells. Ann Hematol 2008;87:431-438.
17. Park C, Ma YD, Choi K. Evidence for the hemangioblast. Exp Hematol 2005;33:965-970.
18. Miyamoto Y, Suyama T, Yashita T et al. Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J Mol Cell Cardiol 2007;43:627-635.
19. Kucia M, Reca R, Jala VR et al. Bone marrow as a home of heterogeneous populations of non-hematopoietic stem cells. Leukemia 2005;19:1118-1127.
20. Deb A, Wang S, Skelding KA et al. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 2003;107:1247-1249.
21. Rovó A, Gratwohl A. Plasticity after allogeneic hematopoietic stem cell transplantation. Biol Chem 2008;389:825-836.
22. Maltais S, Perrault LP, Ly HQ. The bone marrow-cardiac axis: Role of endothelial progenitor cells in heart failure. Eur J Cardiothorac Surg 2011;39:368-374.
23. Kollet O, Shivtiel S, Chen YQ et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 stem cell recruitment to the liver. J Clin Invest 2003;112:160-169.
24. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001;195:229-235.
25. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
26. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
27. Schmidt-Lucke C, Rössig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987.
28. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353: 999-1007.
29. Takahashi M, Li TS, Suzuki R et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 2006;291:H886-H893.
30. Kubal C, Sheth K, Nadal-Ginard B et al. Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans. J Thorac Cardiovasc Surg 2006;132:1112-1118.
31. Yin AH, Miraglia S, Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90: 5002-5012.
32. Ito Y, Hamazaki TS, Ohnuma K et al. Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol 2007;127:1052-1060.
33. Kordes C, Sawitza I, Müller-Marbach A et al. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun 2007; 352:410-417.
34. Sagrinati C, Netti GS, Mazzinghi B et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17:2443-2456.
35. Richardson GD, Robson CN, Lang SH et al. CD133+, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004;117:3539-3545.
36. Kuçi S, Wessels JT, Bühring HJ et al. Identification of a novel class of human adherent CD34-stem cells that give rise to SCID-repopulating cells. Blood 2003;101:869-876.
37. Koutna I, Peterkova M, Simara P et al. Proliferation and differentiation potential of CD133 and CD34 populations from the bone marrow and mobilized peripheral blood. Ann Hematol 2011;90:127-137.
38. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34() cells identifies a population of functional endothelial precursors. Blood 2000; 95:952-958.
39. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
40. Asahara T, Masuda H, Takahasi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
41. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779.
42. Takahashi T, Kalka C, Mashuda H et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5: 434-438.
43. Crosby JR, Kaminsky WE, Schatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000;87:728-730.
44. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436.
45. Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands and cytokines. Circulation 2001;104:1046-1052.
46. Gnecchi M, Zhang Z, Ni A et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204-1219.
47. Tongers J, Roncalli JG, Losordo DW. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 2010;79:200-206.
48. Cuende N, Izeta A. Clinical translation of stem cell therapies: A bridgeable gap. Cell Stem Cell 2010;6:508-512.